Peggy A Hannon Selected Research

ethylenebis(isothiocyanate) (EBIS)

1/2022	Evaluating Uptake of Evidence-Based Interventions in 355 Clinics Partnering With the Colorectal Cancer Control Program, 2015-2018.
1/2022	Pathways to Employee Outcomes in a Workplace Health Promotion Program.
4/2021	Optimizing Implementation in Cancer Control (OPTICC): protocol for an implementation science center.
3/2021	Local Health Jurisdiction Staff Deliver Health Promotion to Small Worksites, Washington.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peggy A Hannon Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 11/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2017
2	Chronic Disease (Chronic Diseases) 01/2022 - 03/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2021
1	Lung Neoplasms (Lung Cancer) 04/2021

Drug/Important Bio-Agent (IBA)

4	ethylenebis(isothiocyanate) (EBIS)IBA 01/2022 - 03/2021
1	Aligeron (AS 2)IBA 03/2017
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 11/2014

Therapy/Procedure

1	Continuity of Patient Care 04/2021